Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for SKIN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.224M
March 31, 2026 -20.91M
December 31, 2025 -0.512M
September 30, 2025 -0.803M
June 30, 2025 -173.36M
March 31, 2025 -0.25M
December 31, 2024 -0.77M
September 30, 2024 -0.204M
June 30, 2024 -98.75M
March 31, 2024 -58.62M
December 31, 2023 -31.36M
September 30, 2023 -2.35M
Date Value
June 30, 2023 -1.546M
March 31, 2023 -2.195M
December 31, 2022 -102.48M
September 30, 2022 -100.00M
June 30, 2022 -1.98M
March 31, 2022 -0.783M
December 31, 2021 -169.42M
September 30, 2021 637.78M
June 30, 2021 128.67M
March 31, 2021 4.377M
December 31, 2020 -0.92M
September 30, 2020 -1.344M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
BioForce Nanosciences Holdings, Inc. 0.0209M
CCA Industries, Inc. -0.2865M
Cyanotech Corp. -0.08M
The Estée Lauder Companies, Inc. -30.00M
Edgewell Personal Care Co. -7.30M